Search results
Author(s):
Rebecca Seidel
Added:
1 year ago
Following the announcement of Medtronic's acquisition of Affera, hereRebecca Seidel, President, Cardiac Ablation Solutions, Medtronic discusses the burden presented by cardiac arrhythmias, the strategic appeal of Affera's portfolio, the perceived real-world benefits of the system, and the remaining challenges for better patient care.
Discussion Points:
1. The prevalence of cardiac…
View more
David DeLurgio
Research Area(s) / Expertise:
Job title: Director of Electrophysiology
Author
Christian Besler
Author
Author(s):
Tarv Dhanjal
,
Daniel Steven
,
Daniel Rodriguez
,
et al
Start date:
Jan 21, 2021
View more
William H Sauer
Author
Author(s):
Irum D Kotadia
,
Steven E Williams
,
Mark O’Neill
Added:
3 years ago
AF is the most common sustained cardiac arrhythmia and radiofrequency is the dominant energy source used for atrial ablation. Owing to an ageing population and the increasing burden of cardiovascular disease, the prevalence of AF, particularly in developed countries, is increasing.1,2 With increasing prevalence comes additional financial burden.3 It is paramount that AF therapy is effective in…
View more
Rhythm Interventions Online 2023 - On Demand
Video Series
Author(s):
Raymond Pranata
,
Giky Karwiky
,
Mohammad Iqbal
Added:
3 months ago
Author(s):
Eun-Jeong Kim
,
Giovanni Davogustto
,
William G Stevenson
,
et al
Added:
3 years ago
Myocardial scars from infarction or replacement fibrosis in non-ischaemic cardiomyopathies are the common substrate for sustained monomorphic ventricular tachycardia (VT).1,2 In selected patients at high risk of ventricular arrhythmias, placement of an implantable cardioverter-defibrillator (ICD) is effective for prevention of sudden cardiac death.2 Although ICDs are effective in terminating VT…
View more
Author(s):
Maya S Verma
,
Maria Terricabras
,
Atul Verma
Added:
2 years ago